Understand the source comparison
Best Peptides for Back Pain: Mechanism Comparison
BPC-157 VEGF upregulation, angiogenesis, collagen type I deposition Rodent tendon models show 30–40% faster repair; no large human trials 250–500 mcg daily SubQ Best for soft tissue microtears in ligaments and fascia where angiogenesis is the limiting factor T
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, angiogenesis, collagen type I deposition
- Rodent tendon models show 30–40% faster repair; no large human trials
- 250–500 mcg daily SubQ
- Best for soft tissue microtears in ligaments and fascia where angiogenesis is the limiting factor
- TB-500
- Actin binding, cell migration, anti-inflammatory cytokine downregulation
- Equine tendon studies show reduced TNF-alpha, IL-6; case series only in humans
- Loading: 2–2.5 mg 2×/week for 4–6 weeks; Maintenance: 2 mg weekly
- Most effective when inflammation perpetuates injury. Chronic pain with elevated inflammatory markers
- Thymosin Beta-4
- Actin modulation, immune regulation, T-cell activation
- Broader immunomodulatory evidence but less specific musculoskeletal data than TB-500
- 5–10 mg 2×/week loading; 5 mg weekly maintenance
- Theoretical benefit in autoimmune-like tissue responses; less direct collagen repair than BPC-157